<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02266264</url>
  </required_header>
  <id_info>
    <org_study_id>MED-R2R-200</org_study_id>
    <nct_id>NCT02266264</nct_id>
  </id_info>
  <brief_title>Hyperglycemia and Effects of Daily 100 mg Versus 200 mg of Hydrocortisone Therapy in Patients With Septic Shock</brief_title>
  <official_title>Hyperglycemia and Effects of Daily 100 Milligrams Versus 200 Milligrams of Hydrocortisone Therapy in Patients With Septic Shock: A Double-Blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Srinakharinwirot University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Srinakharinwirot University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare hyperglycemia and other effects, include 28-day
      mortality and time to reversal of shock between 100 milligrams and 200 milligrams of
      hydrocortisone as initial dosage in patients with septic shock.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intervention group will be received 100 milligrams per day of hydrocortisone on the first
      three day the taper off, whereas the control group will be received 200 milligrams per day of
      hydrocortisone on the first three day the taper off. Hyperglycemia rate will be monitored
      every 6 hours after hydrocortisone is started until 24 hours after it is stopped.

      Also, 28-day mortality will be follow after hydrocortisone is started.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hyperglycemia</measure>
    <time_frame>two years</time_frame>
    <description>Proportion of hyperglycemic patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>two years</time_frame>
    <description>The number of the patients who died before or at 28 days after enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to shock reversal</measure>
    <time_frame>two years</time_frame>
    <description>The dates when vasopressors can be stopped.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>100 milligrams of hydrocortisone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 milligrams per day of hydrocortisone is the starting dosage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>200 milligrams of hydrocortisone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 milligrams per day of hydrocortisone is the starting dosage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <description>Subjects will be divided into two groups by randomization. The intervention-group will be received 100 milligrams per day of hydrocortisone and the control-group will be received 200 milligrams per day of hydrocortisone in the first three days after enrollment.</description>
    <arm_group_label>100 milligrams of hydrocortisone</arm_group_label>
    <arm_group_label>200 milligrams of hydrocortisone</arm_group_label>
    <other_name>solu cortef</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Septic shock

          -  Adequate fluid resuscitation and vasopressor therapy are unable to maintain
             hemodynamic stability

        Exclusion Criteria:

          -  Receive systemic steroid in past 3 months

          -  Established adrenal insufficiency

          -  Currently used in chemotherapy or immunosuppressive agents

          -  Radiotherapy currently received

          -  Known HIV infection

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kanchana Ngaosuwan, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine, Faculty of Medicine, Srinakharinwirot University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medicine, Faculty of Medicine, Srinakharinwirot University</name>
      <address>
        <city>Ongkharak</city>
        <state>Nakhon nayok</state>
        <zip>26120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2014</study_first_submitted>
  <study_first_submitted_qc>October 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2014</study_first_posted>
  <last_update_submitted>October 4, 2017</last_update_submitted>
  <last_update_submitted_qc>October 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Srinakharinwirot University</investigator_affiliation>
    <investigator_full_name>Kanchana Ngaosuwan</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

